Form Bio Co. Ltd. Capital Reinvestment Ratio

Latest as of September 2022: 3.43x

Form Bio Co. Ltd. capital reinvestment ratio. Form Bio Co. Ltd. (377220) has a Capital Reinvestment Ratio of 3.43x as of September 2022, meaning it reinvests 3% of its operating cash flow (₩3.08 Billion) in capital expenditures (₩10.55 Billion). Check 377220 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

3.43x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.08 Billion
KRW

Capital Expenditures

₩10.55 Billion
KRW

Data as of

Sep 2022
Most recent filing

Capital Reinvestment Ratio of Form Bio Co. Ltd. (2019–2020)

Capital reinvestment ratio of Form Bio Co. Ltd. from 2019 to 2020. This chart tracks Form Bio Co. Ltd.'s Capital Reinvestment Ratio across 2 annual periods. Also explore Form Bio Co. Ltd. (377220) equity growth momentum to track the company's year-over-year net asset growth rate.

Form Bio Co. Ltd. Capital Reinvestment Ratio by Year (2019–2020)

Form Bio Co. Ltd. capital reinvestment ratio by year from 2019 to 2020. For the full cash flow conversion analysis, see 377220 cash generation efficiency.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2020 0.42x ₩15.61 Billion ₩6.63 Billion ▲ +5.6%
2019 0.40x ₩5.68 Billion ₩2.28 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow